Daily Patient's Relief From Pruritus and Sleep Disturbance Over One-Month Treatment with Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Multicenter Prospective Study

Dermatitis. 2024 Oct 3. doi: 10.1089/derm.2024.0335. Online ahead of print.
No abstract available

Publication types

  • Letter